These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 6300667)
21. Roles of UDP-glucuronosyltransferase in the inactivation of benzo(a)pyrene. Bock KW; Bock-Hennig BS; Lilienblum W; Pfeil H; Volp RF Adv Exp Med Biol; 1981; 136 Pt A():53-73. PubMed ID: 6283814 [No Abstract] [Full Text] [Related]
22. Metabolic inactivation of mutagenic benzo(a)pyrene metabolites: significance to carcinogenicity and implications for in vitro tests. Glatt HR; Platt KL; Vogel K; Bücker M; Billings R; Oesch F Dev Toxicol Environ Sci; 1980; 8():181-6. PubMed ID: 6273103 [No Abstract] [Full Text] [Related]
23. Control by gastrointestinal hormones of the hydroxylation of the carcinogen benzo(a)pyrene and other xenobiotics in rat colon. Fang WF; Strobel HW Cancer Res; 1981 Apr; 41(4):1407-12. PubMed ID: 6260337 [No Abstract] [Full Text] [Related]
24. Selenium modified mutagenicity and metabolism of benzo[a]pyrene in an S9-dependent system. Teel RW; Kain SR Mutat Res; 1984 Jun; 127(1):9-14. PubMed ID: 6328289 [TBL] [Abstract][Full Text] [Related]
25. Induction of the rat hepatic microsomal mixed-function oxidases by two aza-arenes. A comparison with their non-heterocyclic analogues. Ayrton AD; Trinick J; Wood BP; Smith JN; Ioannides C Biochem Pharmacol; 1988 Dec; 37(23):4565-71. PubMed ID: 3060123 [TBL] [Abstract][Full Text] [Related]
26. Benzo[a]pyrene carcinogenesis: a biochemical selection mechanism. Selkirk JK J Toxicol Environ Health; 1977 Jul; 2(6):1245-58. PubMed ID: 328915 [TBL] [Abstract][Full Text] [Related]
27. Metabolic properties of in vitro systems. Dipple A; Bigger CA Ann N Y Acad Sci; 1983; 407():26-33. PubMed ID: 6309053 [No Abstract] [Full Text] [Related]
28. S-Adenosyl-L-methionine is a carbon donor in the conversion of benzo[alpha]pyrene to 6-hydroxymethylbenzo[alpha]pyrene by rat liver S-9. Flesher JW; Stansbury KH; Sydnor KL Cancer Lett; 1982; 16(1):91-4. PubMed ID: 6288234 [TBL] [Abstract][Full Text] [Related]
29. Metabolism of the mutagenic environmental pollutant, 6-nitrobenzo[a]pyrene: metabolic activation via ring oxidation. Fu PP; Chou MW; Yang SK; Beland FA; Kadlubar FF; Casciano DA; Heflich RH; Evans FE Biochem Biophys Res Commun; 1982 Apr; 105(3):1037-43. PubMed ID: 7046751 [No Abstract] [Full Text] [Related]
30. The formation of benzo [a] pyrene - deoxyribonucleoside adducts in vivo and in vitro. Ashurst SW; Cohen GM Carcinogenesis; 1982; 3(3):267-73. PubMed ID: 6282487 [TBL] [Abstract][Full Text] [Related]
31. Rat liver homogenate (S9)-mediated binding of benzo[alpha]pyrene to DNA in V79 cells, V79 cell nuclei and aqueous solution. Sebti SM; Baird WM Mutat Res; 1984 Feb; 125(2):307-14. PubMed ID: 6321977 [TBL] [Abstract][Full Text] [Related]
32. Differences in benzo(a)pyrene metabolism between rodent liver microsomes and embryonic cells. Selkirk JK; Croy RG; Wiebel FJ; Gelboin HV Cancer Res; 1976 Dec; 36(12):4476-9. PubMed ID: 1000495 [TBL] [Abstract][Full Text] [Related]
33. [Quantitative evaluation of the mutagenic potential of benzo(a)pyrene by in vitro and in vivo tests]. Pashin IuV; Bakhitova LM; Bentkhen TI Vopr Onkol; 1984; 30(7):90-3. PubMed ID: 6087560 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of benzo(a)pyrene and benzo(a)pyrene 7,8-dihydrodiol metabolism by benzo(a)pyrene quinones. Shen AL; Fahl WE; Wrighton SA; Jefcoate CR Cancer Res; 1979 Oct; 39(10):4123-9. PubMed ID: 113086 [No Abstract] [Full Text] [Related]
35. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene. Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665 [TBL] [Abstract][Full Text] [Related]
36. The effect of substrates and inhibitors of monoamine oxidase on hepatic dimethylnitrosamine metabolism and mutagenicity. Lake BG; Rowland IR; Harris RA; Collins MA; Phillips JC; Cottrell RC; Gangolli SD Adv Exp Med Biol; 1981; 136 Pt B():1143-7. PubMed ID: 6283820 [No Abstract] [Full Text] [Related]
37. Metabolism and covalent binding to DNA of 7-methylbenzo(a)pyrene. Kinoshita T; Konieczny M; Santella R; Jeffrey AM Cancer Res; 1982 Oct; 42(10):4032-8. PubMed ID: 7049354 [TBL] [Abstract][Full Text] [Related]
38. Study of the mutagenic activity of 6 hepatotoxic pharmaceutical drugs in the Salmonella typhimurium microsome test, and the HGPRT and Na+/K+ ATPase system in cultured mammalian cells. Dayan J; Deguingand S; Truzman C Mutat Res; 1985 Jul; 157(1):1-12. PubMed ID: 2989681 [TBL] [Abstract][Full Text] [Related]
39. Use of metabolic activation systems of tulip bulbs in the Ames test for environmental mutagens. Higashi K; Ikeuchi K; Karasaki Y Bull Environ Contam Toxicol; 1982 Nov; 29(5):505-10. PubMed ID: 6295531 [No Abstract] [Full Text] [Related]
40. Metabolism of benzo[a]pyrene in rat prostate glands following 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure. Lee IP; Suzuki K; Nagayama J Carcinogenesis; 1981; 2(9):823-31. PubMed ID: 6271412 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]